US 8846629
Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma
granted A61PA61P35/00
Quick answer
US patent 8846629 (Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma) held by The Regents of the University of California expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P35/00